RA is a progressive inflammatory autoimmune disease with articular and systemic effects. Its
exact cause is unknown, but genetic and environmental factors are contributory. T cells, B …

Objectives: To develop evidence-based EULAR recommendations for cardiovascular (CV)
risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and …

Epidemiology is the study of the distribution and determinants of disease in human
populations. Over the past decade there has been considerable progress in our …

Rheumatoid arthritis (RA) is a chronic inflammatory joint disease characterized by a
distinctive pattern of bone and joint destruction. RA patients have an increased risk of death …

Objective. SSc is known as the most severe connective tissue disorder, and to be associated
with a high mortality risk. Some improvements in therapy for SSc have been achieved in …

Objectives: The phase III RADIATE study examined the efficacy and safety of tocilizumab, an
anti-IL-6 receptor monoclonal antibody in patients with rheumatoid arthritis (RA) refractory to …

Objectives To investigate the impact of disease activity, the course of the disease, its
treatment over time, comorbidities and traditional risk factors on survival. Methods Data of …

The risk of cardiovascular disease is increased in patients with rheumatoid arthritis
compared with the general population owing to the influence of traditional and non …

Objective. To describe the longterm safety and efficacy profile of tofacitinib in patients with
moderate to severe active rheumatoid arthritis (RA). Methods. Data were pooled from 2 open …

Cardiovascular disease (CVD) is markedly increased in patients with rheumatoid arthritis
partly due to accelerated atherosclerosis from chronic inflammation. Traditional …